Health Concerns Linked to Ozempic, Wegovy, Rybelsus, Mounjaro & Trulicity While Ozempic, Wegovy, Rybelsus, Mounjaro, and Trulicity may benefit people who struggle with diabetes or obesity, they have been linked to serious health issues
This slows digestion, reduces appetite, stabilizes blood sugar, and leads to significantly lower caloric intake
Patients who took Ozempic versus placebo also cut their risk of major heart problems by 18%
The current observational study therefore aimed to provide further real-world evidence concerning the comparative effectiveness of semaglutide OW versus SGLT2is in relation to change in weight, body mass index (BMI), HbA1c, and composite outcomes, as well as all-cause HCRU and medical costs, in patients with T2D over a 1-year period